IRRA Itama Ranoraya Tbk


Saham IRRA Itama Ranoraya Tbk - Berita, Prospek, dan Analisa - :
Stocks Asia - Berita saham, analisis saham, dan prospek saham
Tip: Gunakan untuk menyimpan saham-saham favorit
IRRA IRRA secured a contract of 88 million ADSs for vaccinations | IDNFinancials
06 Dec 2021 18:34 (1 bulan 16 hari lalu) - JAKARTA. PT Itama Ranoraya Tk (IRRA), a medical equipment manufacturer and distributor, has recently obtained a supply contract for 88.7 million units of Auto Disable Syringes (ADS) from the government to cover the needs of COVID-19 vaccination programs. Heru Firdausi Syarif, President Director of IRRA, claimed that his company is ready to meet the demand for syringes for vaccination programs. Regarding the distribution, the company would gain support from the new factory that belongs to one of its subsidiaries, PT Oneject Indonesia. “We, through Oneject, definitely prioritise the allocation of syringes for state programs like vaccinations ...
IRRA Itama Ranoraya spares IDR 120 billion for buyback | IDNFinancials
29 Nov 2021 09:27 (1 bulan 24 hari lalu) - JAKARTA – PT Itama Ranoraya Tbk (IRRA) allocates IDR 120 billion to repurchase a maximum of 75 million shares traded in the exchange. This corporate action would take three months to be done, starting last week on November 26, 2021. Pratoto Satno Raharjo, Director of Itama Ranoraya, announced that this corporate action would use the company’s internal cash. Thus, it won’t affect the company’s revenue and financial condition. “The net profit per share as of December 2020 that reached IDR 40 each would increase to IDR 68.75 per share after this buyback,” he said in the information disclosure on Monday (29/11). According to Raharjo, the compan ...
IRRA Itama Ranoraya soared in Q3 2021 | IDNFinancials
26 Oct 2021 13:53 (2 bulan 28 hari lalu) - JAKARTA – PT Itama Ranoraya Tbk (IRRA), health equipment manufacturer, scored operating revenue of IDR 1.08 trillion in Q3 2021, a massive upturn from the number reported in 2020 of IDR 141.05 billion. This surge resulted from the all-time high demand for COVID-19 test kits in the middle of this ongoing pandemic since early 2020. Heru Firdaus Syarif, President Director of Itama Ranoraya, revealed that the highest revenue came from in vitro diagnostic products sales of IDR 1.04 trillion. Then, it was followed by sterile, non-electromedical equipment sales of IDR 29.64 billion and other products sales of IDR 9.47 billion. In comparison, in Q3 ...
IRRA DGIK Parent company of Itama Ranoraya acquires 51.58% of DGIK | IDNFinancials
07 Oct 2021 13:00 (3 bulan 17 hari lalu) - JAKARTA. PT Global Dinamika Kencana, the parent company of PT Itama Ranoraya Tbk (IRRA), is now the new shareholder of PT Nusa Konstruksi Enjiniring Tbk (DGIK) after purchasing 51.85% of its shares. Global Dinamika Kencana took over 51.85% of the shares from four different old shareholders. They were PT Lintas Kebayoran Kota, who used to own 34.12% of the shares, PT Lokasindo Aditama of 7.60%, PT Rezeki Segitiga Emas 9.32%, and PT Multidaya Hutama Indokarunia 0.81%. The acquisition was executed with a price of IDR 80 each. Therefore, the total expenditure of Global Dinamika Kencana for this transaction amounted to IDR 229.85 billion. “The ...
IRRA Itama Ranoraya scored IDR 198.8 billion from selling treasury stock | IDNFinancials
01 Oct 2021 13:43 (3 bulan 23 hari lalu) - JAKARTA – PT Itama Ranoraya Tbk (IRRA) collected IDR 198.8 billion of fresh funds from selling 100 million shares of treasury stock gained from the buyback. The said funds would be channelled to fund PT Oneject Indonesia (Oneject) acquisition. Pratoto Setno Rajaharjo, Financial Director of Itama Ranoraya, announced that the execution price for the said treasury stock sales amounted to IDR 1,998 per share. It is 227% higher than the average price during the buyback of IDR 527 per share. “The proceeds would raise the company’s equity as much as the treasury stock value, after deducting the sales costs,” he stated in the press release, quoted t ...
IRRA Going international, IRRA to acquire 51% of Oneject | IDNFinancials
30 Sep 2021 05:29 (3 bulan 24 hari lalu) - JAKARTA. PT Itama Ranoraya Tbk (IRRA) is in the process of purchasing 51% of PT Oneject Indonesia’s (Oneject) shares. With this acquisition, IRRA aims to be a global player in the medical equipment manufacturing sector, meeting the demands from both the domestic and international markets. The acquisition process was initiated not too long ago with a conditional sales-purchase agreement. This step supports the company’s vision of transforming into a high-tech manufacturer in the healthcare sector. Oneject is the second largest Auto Disable Syringe (ADS) manufacturer in Asia. It had sold its products to Europe, Asia, and UNICEF. The press rel ...
IRRA IRRA sells 100 million treasury shares for IDR 1,988 | IDNFinancials
17 Sep 2021 06:33 (4 bulan 7 hari lalu) - JAKARTA – PT Itama Ranoraya Tbk (IRRA), a health device distributor, would discharge 100 units of shares gained via buyback for IDR 1.988 per share to PT Global Dinamika Kencana (GDK). Pratoto Satno Raharjo, Financial Director of Itama Ranoraya, reveals that the buyback shares transfer is conducted under specific circumstances. Thus, it would not be preceded by the Annual General Shareholders Meeting. “The proceeds of a buyback of 100 million shares for IDR 527 each in average, along with the realised budget used for the buyback, amount to IDR 59.91 billion,” he further explains in the information disclosure, quoted Friday (17/9). According ...
IRRA Itama Ranoraya secures a purchasing contract for 50 million syringes | IDNFinancials
01 Sep 2021 07:54 (4 bulan 23 hari lalu) - JAKARTA – PT Itama Ranoraya Tbk (IRRA), a medical equipment and tools distributor, obtains a contract involving a purchase of 50 million auto-disable syringes (ADS) from the Ministry of Health. The capacity of these specific needles is 0.3 ml, which differs from other vaccine syringes that use 0.5 ml syringes. In a press release quoted today (1/9), Heru Firdaus Syarif, President Director of Itama Ranoraya, claims that the syringes ordered by the Health Ministry would be utilised to inject Pfizer/BioNTech vaccines. These are COVID-19 vaccines produced by Pfizer Inc and BioNTech. “This contract would be the first in this year, acquired from th ...
IRRA Itama Ranoraya Kantongi Kontrak 50 Juta Jarum Suntik dari Menkes - Korporasi Katadata.co.id
31 Aug 2021 21:21 (4 bulan 23 hari lalu) - Emiten peralatan kesehatan, PT Itama Ranoraya Tbk (IRRA) memperoleh kontrak pembelian 50 juta jarum suntik Auto Disable Syringe (ADS) untuk program vaksinasi pemerintah melalui Kementerian Kesehatan. Penandatanganan kontrak perjanjian jual dan beli dilakukan pada 19 Agustus 2021, termasuk proses pendistribusian. Produk jarum suntik ADS yang dibeli berukuran khusus 0,3 ml berbeda dengan produk jarum suntik ADS yang digunakan untuk vaksin lainnya seperti Astra Zeneca, Sinovac maupun Moderna yang menggunakan ADS berukuran 0,5 ml. Jarum suntik berukuran 0,3 ml tersebut akan diperuntukkan khusus untuk vaksin Pfizer/BioNTech. Dalam pasar jarum su ...
IRRA PT Itama Ranoraya Tbk Raih Kontrak 50 Juta Jarum Suntik ADS
Tag: Blog
30 Aug 2021 13:30 (4 bulan 25 hari lalu) - PT Itama Ranoraya Tbk (IRRA) emiten yang bergerak di bidang peralatan dan perlengkapan medis berteknologi tinggi (HiTech Healthcare Solutions) mendapatkan kontrak pembelian 50 juta jarum suntik auto disable syringe (ADS) dari Pemerintah melalui Kementrian Kesehatan (Kemenkes) untuk program vaksinasi pemerintah. Produk jarum suntik ADS yang dibeli tersebut berukuran khusus 0,3 ml, berbeda dengan produk jarum suntik ADS yang digunakan untuk vaksin lainnya seperti Asta Zeneca, Sinovac maupun Moderna yang menggunakan ADS berukuran 0,5 ml. Penandatanganan kontrak sales and purchase agreement (SPA) dilakukan pada 19 Agustus 2021 termasuk proses ...
Mode seleksi ketat (strict search) ON. Klik di sini untuk melihat lebih banyak artikel.
  Artikel 1 sampai 10